The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS

Objective: To explore the long-term outcomes of patients with clinically isolated syndromes from the Barcelona cohort. Methods: We selected patients with a follow-up longer than 10 years to (1) estimate the risks of multiple sclerosis (MS) and disability accumulation according to the baseline number of T2 lesions and to compare treated versus untreated patients and early versus delayed treatment, and (2) to study baseline features of patients with aggressive MS (Expanded Disability Status Scale (EDSS) ⩾6.0 at 10 years). Results: In all, 401 patients were included (mean follow-up of 14.4 (standard deviation of 2.9) years). A higher number of T2 lesions was associated with an earlier MS diagnosis and an earlier risk of irreversible disability. Early treatment was associated with a decreased risk of EDSS of 3.0: adjusted hazard ratio = 0.4, 95% confidence interval = (0.2, 0.7). Patients with aggressive MS differed in their baseline brain magnetic resonance images: The median (interquartile range) number of T2 lesions and contrast-enhancing lesions (CEL) was 71 (28–95) versus 7 (1–19) and 3 (1–24) versus 0 (0–1), respectively. The cut-offs that better classified patients with aggressive MS were 20 for T2 lesions and 2 for CEL. Conclusion: Although MS natural history is changing, a high lesion load at onset is helpful to identify patients at risk of presenting an aggressive MS.

[1]  Xavier Montalban,et al.  Treatment decisions in multiple sclerosis — insights from real-world observational studies , 2017, Nature Reviews Neurology.

[2]  F. Barkhof,et al.  The 11-year long-term follow-up study from the randomized BENEFIT CIS trial , 2016, Neurology.

[3]  Alyssa H. Zhu,et al.  Long‐term evolution of multiple sclerosis disability in the treatment era , 2016, Annals of neurology.

[4]  Pierre Grammond,et al.  Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis , 2016, Annals of neurology.

[5]  À. Rovira,et al.  Defining high, medium and low impact prognostic factors for developing multiple sclerosis. , 2015, Brain : a journal of neurology.

[6]  M. Freedman,et al.  Aggressive multiple sclerosis: proposed definition and treatment algorithm , 2015, Nature Reviews Neurology.

[7]  J. Lechner-Scott,et al.  Predictors of disability worsening in clinically isolated syndrome , 2015, Annals of clinical and translational neurology.

[8]  O. Nerman,et al.  The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset , 2015, Journal of Neurology.

[9]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[10]  A. Thompson,et al.  Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. , 2008, Brain : a journal of neurology.

[11]  D. Paty,et al.  Disability progression in multiple sclerosis is slower than previously reported , 2006, Neurology.

[12]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[13]  Gavin Giovannoni,et al.  Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. , 2005, Archives of neurology.

[14]  S. Weigand,et al.  Change in MS-related disability in a population-based cohort , 2004, Neurology.

[15]  David H. Miller,et al.  A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. , 2002, The New England journal of medicine.

[16]  C Confavreux,et al.  Relapses and progression of disability in multiple sclerosis. , 2000, The New England journal of medicine.

[17]  A. Thompson,et al.  The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. , 1998, Brain : a journal of neurology.

[18]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. , 1989, Brain : a journal of neurology.

[19]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[20]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.